Home › Funds › Empyrean Capital Partners, LP › CAH

Empyrean Capital Partners, LP position in CAH

CARDINAL HEALTH INC · Health Care

Empyrean Capital Partners, LP reported holding 184,200 shares of CAH (CARDINAL HEALTH INC) in its Q2 2026 13F filing — a position valued at US$43.8M, representing 1.45% of its reported portfolio and ranking #22 among its reported holdings. Empyrean Capital Partners, LP has disclosed CAH holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)184.20K sh
Reported value held$43.76M
Portfolio Weight1.45%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Empyrean Capital Partners, LP's CAH position evolved

Empyrean Capital Partners, LP first disclosed a stake in CAH in Q1 2025 at 379,000 shares (US$52.2M). The position peaked in Q3 2025 at 357,400 shares, worth US$56.1M. Across 6 filings, Empyrean Capital Partners, LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 184,200 shares valued at US$43.8M — a reduction of -63,600 shares quarter over quarter.. Notable position changes include a 31% trim in Q4 2025 (shares rose 3% over the following quarter), a 26% trim in Q2 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 379.00K $52.21M New
Q2 2025 311.30K $52.30M Reduce
Q3 2025 357.40K $56.10M Add
Q4 2025 247.80K $50.92M Reduce
Q1 2026 247.80K $52.36M Hold
Q2 2026 184.20K $43.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAH and 13F data

CAH (CARDINAL HEALTH INC) is a Health Care company. 42 other funds we track also report a position in CAH — the largest reported positions include Wellington Management Group (US$3.53B), WELLINGTON MANAGEMENT GROUP LLP (US$3.53B), Banque Cantonale Vaudoise (US$3.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAH

All CAH fund holders →

FAQ

How long has Empyrean Capital Partners, LP held CAH?

Empyrean Capital Partners, LP has disclosed CAH holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Empyrean Capital Partners, LP's current position in CAH?

As of Q2 2026, Empyrean Capital Partners, LP holds 184.20K shares of CAH (CARDINAL HEALTH INC), valued at $43.76M, representing 1.45% of its reported portfolio and ranking #22.

Has Empyrean Capital Partners, LP been buying or selling CAH?

In the latest 13F filing (Q2 2026), Empyrean Capital Partners, LP reduced its position in CAH. The position peaked in Q3 2025 at 357.40K shares.

Which other funds hold CAH?

Other major institutional holders of CAH include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Banque Cantonale Vaudoise, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.